Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $205,423 - $228,481
-2,382 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$71.83 - $95.48 $408,425 - $542,899
-5,686 Reduced 70.48%
2,382 $219,000
Q4 2020

Feb 17, 2021

BUY
$67.0 - $84.39 $42,545 - $53,587
635 Added 8.54%
8,068 $590,000
Q3 2020

Nov 19, 2020

BUY
$55.23 - $79.93 $1,270 - $1,838
23 Added 0.31%
7,433 $577,000
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $223,782 - $422,221
7,410 New
7,410 $412,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.